OTCMKTS:MRNA - Marina Biotech Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.91 0.00 (0.00 %)
(As of 06/24/2018 12:59 PM ET)
Previous Close$0.91
Today's Range$0.87 - $0.91
52-Week Range$0.65 - $5.00
Volume2,015 shs
Average Volume5,128 shs
Market Capitalization$9.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58
Marina Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of proprietary drug therapeutics primarily for hypertension, arthritis, pain, and oncology in the United States, Europe, and internationally. The company offers Prestalia, a single-pill fixed dose combination (FDC) of perindopril argenine, an angiotensin-converting-enzyme inhibitor; and amlodipine besylate, a calcium channel blocker for the treatment of hypertension. Its clinical development programs include IT-102 and IT-103, a celecoxib program drug candidates for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against beta-catenin, combined with IT-102 to suppress polyps in the precancerous syndrome and orphan indication familial adenomatous polyposis; and CEQ508 combined with IT-103 to treat colorectal cancer. The company is headquartered in City of Industry, California.

Receive MRNA News and Ratings via Email

Sign-up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:MRNA
CUSIPN/A
Phone626-964-5788

Debt

Debt-to-Equity RatioN/A
Current Ratio0.02
Quick Ratio0.02

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$680,000.00
Price / Sales14.47
Cash FlowN/A
Price / CashN/A
Book Value$0.04 per share
Price / Book22.75

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-6,210,000.00
Net MarginsN/A
Return on Equity-692.69%
Return on Assets-103.37%

Miscellaneous

Employees7
Outstanding Shares10,810,000

The Truth About Cryptocurrencies

Marina Biotech (OTCMKTS:MRNA) Frequently Asked Questions

What is Marina Biotech's stock symbol?

Marina Biotech trades on the OTCMKTS under the ticker symbol "MRNA."

How were Marina Biotech's earnings last quarter?

Marina Biotech, Inc. (OTCMKTS:MRNA) released its earnings results on Friday, May, 18th. The biotechnology company reported ($0.13) earnings per share for the quarter. View Marina Biotech's Earnings History.

When is Marina Biotech's next earnings date?

Marina Biotech is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Marina Biotech.

Who are some of Marina Biotech's key competitors?

Who are Marina Biotech's key executives?

Marina Biotech's management team includes the folowing people:
  • Dr. Vuong Trieu, Exec. Chairman & Interim CEO (Age 55)
  • Mr. Amit Shah, Chief Financial Officer (Age 52)
  • Mr. Mihir Munsif, Chief Operating Officer (Age 55)
  • Dr. Larn Hwang, Chief Scientific Officer (Age 55)
  • Dr. Peter D. Weinstein Ph.D., J.D., Chief Legal Officer (Age 55)

Has Marina Biotech been receiving favorable news coverage?

News stories about MRNA stock have trended somewhat positive this week, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Marina Biotech earned a news impact score of 0.10 on Accern's scale. They also assigned news stories about the biotechnology company an impact score of 47.79 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Marina Biotech?

Shares of MRNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Marina Biotech's stock price today?

One share of MRNA stock can currently be purchased for approximately $0.91.

How big of a company is Marina Biotech?

Marina Biotech has a market capitalization of $9.84 million and generates $680,000.00 in revenue each year. Marina Biotech employs 7 workers across the globe.

How can I contact Marina Biotech?

Marina Biotech's mailing address is 17870 CASTLETON STREET SUITE 250, CITY OF INDUSTRY CA, 91748. The biotechnology company can be reached via phone at 626-964-5788 or via email at [email protected]


MarketBeat Community Rating for Marina Biotech (MRNA)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Marina Biotech and other stocks. Vote "Outperform" if you believe MRNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.